Save time and get answers to complex questions with AI chat
Excipients list used in dexamethasone creams?Drugpatentwatch skyrizi biologic patent analysis?Cost promethazine price?When oxcarbazepine patent expired?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for Calquence
Calquence (acalabrutinib) is developed and marketed by AstraZeneca. It originated with Acerta Pharma, which AstraZeneca acquired in 2016. If you’d like, I can share current indications, dosing, or recent regulatory updates.
Other Questions About Calquence :